Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Clinical trial NCT02470585 · TERMINATED

Trial details

NCT number: NCT02470585
Sponsor: AbbVie
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Ovarian Cancer Ovarian Neoplasm

Start date: 2015-07-14
Primary completion: 2019-05-03
Enrollment: 1140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.